
201 - 500 employees
Founded 2013
🏥 Healthcare
🏭 Manufacturing
💼 Consulting
💰 $150M Post-IPO Equity on 2022-10
Healthcare • Manufacturing • Consulting
Recursion is a pioneering biopharmaceutical company that leverages advanced technology to drive the industrialization of drug discovery. It combines hardware, software, and vast datasets to decode complex biological information, aiming to create a next-generation platform for developing therapeutics. With a focus on AI and collaboration with industry leaders like Exscientia, Recursion is at the forefront of TechBio, transforming the landscape of drug discovery and development. The company is a proud founding member of BioHive, underscoring its commitment to innovation and leadership in the life sciences sector. Operating with over 60 petabytes of proprietary data and a significant pipeline, Recursion aims to radically improve lives by exploring broad therapeutic areas in partnership with other entities.
Selected: 🆕 Date Added.
🕒 September 25
Executive Director leading clinical pharmacology and pharmacometrics for Recursion, a clinical-stage TechBio drug discovery company. Guiding rare disease and oncology programs through modeling, study design, and regulatory strategy.
🇺🇸 United States – Remote
💵 $261.8k - $314.6k / year
💰 $150M Post-IPO Equity on 2022-10
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
🦅 H1B Visa Sponsor
👻 Ghost score 1%
🕒 September 25
Executive Director leading clinical pharmacology and pharmacometrics for Recursion’s rare disease and oncology drug programs. Guiding modeling, clinical studies, and regulatory submissions at a TechBio company.
🇬🇧 United Kingdom – Remote
💵 £136.5k - £167.2k / year
💰 $150M Post-IPO Equity on 2022-10
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 1%
🕒 September 21
Executive Director shaping oncology and immunology clinical assets at Recursion, an AI-powered TechBio company. Driving portfolio strategy, competitive positioning, and data-informed development decisions.
🇺🇸 United States – Remote
💰 $150M Post-IPO Equity on 2022-10
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
👻 Ghost score 13%
🕒 September 9
Senior AI Researcher advancing frontier AI research and applications across drug discovery, design, and translation. Contributing to Recursion’s AI-native platform for developing medicines.
🗽 New York, Utah – Remote
💰 $150M Post-IPO Equity on 2022-10
⏰ Full Time
🟠 Senior
🧠 AI Research Scientist
🦅 H1B Visa Sponsor
👻 Ghost score 20%